News
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

36,758 Results

Type

Article (2364)
Company Profile (39)
Press Release (34355)

Section

Business (14064)
Career Advice (76)
Deals (2067)
Drug Delivery (7)
Drug Development (4059)
Employer Resources (10)
FDA (422)
Job Trends (756)
News (20021)
Policy (1049)

Tag

Date

Today (9)
Last 7 days (48)
Last 30 days (166)
Last 365 days (2784)
2024 (1929)
2023 (2857)
2022 (3750)
2021 (4049)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)

Filters

Type

Article (2364)
Company Profile (39)
Press Release (34355)

Section

Business (14064)
Career Advice (76)
Deals (2067)
Drug Delivery (7)
Drug Development (4059)
Employer Resources (10)
FDA (422)
Job Trends (756)
News (20021)
Policy (1049)

Tag

Date

Today (9)
Last 7 days (48)
Last 30 days (166)
Last 365 days (2784)
2024 (1929)
2023 (2857)
2022 (3750)
2021 (4049)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)

36,758 Results for "akston biosciences".

Sort By

Business

Dr. Linda Rhodes Joins Akston Biosciences’ Board of Directors

Akston Biosciences Corporation, dedicated to accelerating the biologics revolution in Animal Health, today announced the appointment of Linda Rhodes, VMD, PhD to its Board of Directors.

June 17, 2024
·
3 min read
Genetown

Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility

Akston Biosciences, dedicated to accelerating the next revolution in Animal Health, announced the publication in Nature Vaccines of phase II study results for AKS-452, based on Akston’s Ambifect® Fc-fusion protein platform.

February 26, 2024
·
2 min read
Genetown

Akston Biosciences’ AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility

Akston Biosciences’ AKS-107 Study Published in Frontiers in Immunology , Displaying Ambifect ® Platform’s Versatility.

March 11, 2024
·
3 min read
Genetown

Akston Biosciences to Focus on Strong Animal Health Pipeline

Akston Biosciences Corporation announced today that it will focus on inventing, developing, and manufacturing breakthrough protein therapeutics for Companion Animal Health, utilizing its versatile Ambifect™ Fc-fusion platform and its Beverly, Massachusetts cGMP biologics manufacturing facility.

August 17, 2023
·
2 min read
Genetown

Akston Biosciences Receives 2023 Most Innovative Award at Animal Health Summit

Akston Biosciences Corporation, which invents, develops and manufactures breakthrough protein therapeutics for Companion Animal Health, received the 2023 Innovation Award at the just-concluded Animal Health Summit in Kansas City, MO.

August 31, 2023
·
2 min read
Genetown

Akston Biosciences CEO to Present at the 2023 Animal Health Summit in Kansas City

Akston Biosciences Corporation, which invents, develops and manufactures breakthrough protein therapeutics for Companion Animal Health, announced that President & CEO Todd Zion, Ph.D., will present at the 2023 Animal Health Summit in Kansas City, MO on August 28, 2023.

August 28, 2023
·
2 min read
Business

Akston Biosciences Strengthens Board with Addition of John T. Preston

Akston Biosciences Corporation, a clinical-stage biotechnology company, today announced that John T. Preston, a founder of TEM Capital, has joined its Board of Directors.

January 23, 2023
·
3 min read
Drug Development

Akston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, today announced top-line clinical results for its Phase II COVID-19 “universal” booster vaccine, AKS-452.

November 1, 2022
·
3 min read
Genetown

Akston Biosciences CEO to Present at the World Vaccine Congress - Apr 12, 2022

Akston Biosciences Corporation, a developer of new classes of biologics, announced that its president and CEO, Todd Zion, Ph.D., has been invited to present at this year’s World Vaccine Congress.

April 12, 2022
·
3 min read
Drug Development

Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today it dosed the first set of volunteers in an open-label study of AKS-452, its protein subunit COVID-19 vaccine, as a booster.

May 12, 2022
·
5 min read

1 of 3,676

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
Hotbeds
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin